menu search

Viatris (vtrs) gets fda nod for generic drug in dry eye disease

Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Re...

February 4, 2022, 1:45 pm

Viatris (vtrs) gets fda nod for generic drug in dry eye disease

Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Re...

February 4, 2022, 1:45 pm

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...

January 21, 2022, 11:04 am

Here's why you should retain haemonetics (hae) stock for now

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...

October 6, 2021, 10:30 am

Here's why you should retain haemonetics (hae) stock for now

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...

October 6, 2021, 10:30 am

Here's why you should retain haemonetics (hae) stock for now

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...

October 6, 2021, 10:30 am

Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference

FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...

October 6, 2021, 7:33 am

Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference

FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...

October 6, 2021, 7:33 am

Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference

FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...

October 6, 2021, 7:33 am


Search within

Pages Search Results: